ExLibris header image
SFX Logo
Title: Cancer immunotherapy. Neo approaches to cancer vaccines
Source:

Science [0036-8075] Delamarre, L yr:2015


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Schumacher, Ton N. "Neoantigens in cancer immunotherapy." Science 348.6230 (2015): 69-74. Link to SFX for this item
2. Lauren Gravitz, L. "Cancer immunotherapy." Nature 504.7480: 1-. Link to SFX for this item
3. Schreiber, Robert D. "The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer." Elsevier Science, 2016. 25-74. Link to SFX for this item
4. Tran, E. "Immunogenicity of somatic mutations in human gastrointestinal cancers." Science 350.6266 (2015): 1387-90. Link to SFX for this item
5. Cheson, Bruce D. "Rethinking clinical response and outcome assessment in a biologic age." Current oncology reports 17.6 (2015): 452-27. Link to Full Text for this item Link to SFX for this item
6. Joyce, Johanna A. "T cell exclusion, immune privilege, and the tumor microenvironment." Science 348.6230 (2015): 74-80. Link to SFX for this item
7. Allison, James P. "The future of immune checkpoint therapy." Science 348.6230 (2015): 56-61. Link to SFX for this item
8. Rosenberg, Steven A. "Adoptive cell transfer as personalized immunotherapy for human cancer." Science 348.6230 (2015): 62-68. Link to SFX for this item
9. Gubin, M. "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens." Nature 515.7528 (2014): 577-81. Link to Full Text for this item Link to SFX for this item
10. "Cancer immunotherapy." Nature. 552.7685. Link to SFX for this item
11. Klebanoff, Nicholas A. "Prospects for gene-engineered T cell immunotherapy for solid cancers." Nature Medicine 22.1 (2016): 26-36. Link to SFX for this item
12. "Cancer Immunotherapy." Science advances. 342.6165: 1432-1433. Link to SFX for this item
13. McNutt, M. "Cancer immunotherapy." Science 342.6165 (2013): 1417-1417. Link to SFX for this item
14. Dillman, Robert O. "Cancer Immunotherapy." Cancer biotherapy & radiopharmaceuticals 26.1: 1-64. Link to SFX for this item
15. Couzin Frankel, J. "Breakthrough of the year 2013. Cancer immunotherapy." Science 342.6165 (2013): 1432-1433. Link to SFX for this item
16. Mok, Timothy Y. "Identifying Best Practices for and Utilities of the Pharmacy Curriculum Outcome Assessment Examination." American journal of pharmaceutical education. 80.10: 163-163. Link to SFX for this item
17. Yan, J. "Purinyl-cobamide is a native prosthetic group of reductive dehalogenases." Nature Chemical Biology 14.1 (2017): 8-14. Link to SFX for this item
18. Stevanović, S. "Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer." Science 356.6334 (2017): 200-205. Link to SFX for this item
19. Tran, E. "T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer." The New England Journal of Medicine 375.23 (2016): 2255-2262. Link to SFX for this item
20. Nesrua, F O. "Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells." Peptides 1 (1998). Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.